1
|
Zhang L, DeBoer C, Ellison-Barnes A, Berger J, Lawrence CE, Stewart RW, Pecker LH. Thrombocytopenia in a 7-day-old Male. Pediatr Rev 2021; 42:S10-S14. [PMID: 33386351 DOI: 10.1542/pir.2018-0301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Affiliation(s)
- Lindy Zhang
- Departments of Pediatric Hematology, .,Pediatric Oncology
| | | | | | - Jessica Berger
- Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, Philadelphia, PA
| | - Courtney E Lawrence
- Departments of Pediatric Hematology.,Division of Transfusion Medicine, Department of Pathology, and
| | | | - Lydia H Pecker
- Division of Hematology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD
| |
Collapse
|
2
|
Sachs UJ, Wienzek‐Lischka S, Duong Y, Qiu D, Hinrichs W, Cooper N, Santoso S, Bayat B, Bein G. Maternal antibodies against paternal class I human leukocyte antigens are not associated with foetal and neonatal alloimmune thrombocytopenia. Br J Haematol 2020; 189:751-759. [DOI: 10.1111/bjh.16419] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2019] [Accepted: 11/01/2019] [Indexed: 12/30/2022]
Affiliation(s)
- Ulrich J. Sachs
- Institute for Clinical Immunology and Transfusion Medicine Justus‐Liebig‐University Giessen Germany
- German Center for Fetomaternal Incompatibility Giessen Germany
| | - Sandra Wienzek‐Lischka
- Institute for Clinical Immunology and Transfusion Medicine Justus‐Liebig‐University Giessen Germany
- German Center for Fetomaternal Incompatibility Giessen Germany
| | - Yalin Duong
- Institute for Clinical Immunology and Transfusion Medicine Justus‐Liebig‐University Giessen Germany
| | - Dan Qiu
- Institute for Medical Informatics Justus‐Liebig‐University Giessen Germany
| | | | - Nina Cooper
- Institute for Clinical Immunology and Transfusion Medicine Justus‐Liebig‐University Giessen Germany
- German Center for Fetomaternal Incompatibility Giessen Germany
| | - Sentot Santoso
- Institute for Clinical Immunology and Transfusion Medicine Justus‐Liebig‐University Giessen Germany
| | - Behnaz Bayat
- Institute for Clinical Immunology and Transfusion Medicine Justus‐Liebig‐University Giessen Germany
| | - Gregor Bein
- Institute for Clinical Immunology and Transfusion Medicine Justus‐Liebig‐University Giessen Germany
- German Center for Fetomaternal Incompatibility Giessen Germany
| |
Collapse
|
3
|
Okubo M, Nishida E, Watanabe A, Nishizaki N, Obinata K, Azuma F, Matsuhashi M, Watanabe-Okochi N, Tsuno NH, Miyake K, Yamaguchi M, Yoshida K, Ohsaka A. Marked thrombocytopenia in a neonate is associated with anti-HPA-5b, anti-HLA-A31, and anti-HLA-B55 antibodies. Pediatr Blood Cancer 2019; 66:e27555. [PMID: 30488611 DOI: 10.1002/pbc.27555] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/09/2018] [Revised: 10/03/2018] [Accepted: 10/25/2018] [Indexed: 11/09/2022]
Abstract
Maternal antibodies against human platelet antigen (HPA) and/or human leukocyte antigen (HLA) cause fetal and neonatal alloimmune thrombocytopenia (FNAIT) in 0.09-0.15% of live births. Severe cases account for 5-31% and the frequency of multiple kinds of alloantibodies is 6.9-9% of FNAIT. We present a case of severe FNAIT associated with anti-HPA-5b, anti-HLA-A31, and anti-HLA-B55 antibodies, successfully treated with immunoglobulin and platelet transfusion. The anti-HLA-B55 antibody was detected in the newborn's serum, but disappeared on the 20th day, which was followed by an increase of the platelet count. These findings suggested the potential involvement of an anti-HLA antibody in the pathogenesis of FNAIT.
Collapse
Affiliation(s)
- Mitsuo Okubo
- Department of Transfusion Service, Juntendo University Urayasu Hospital, Urayasu City, Japan.,Department of Transfusion Medicine and Stem Cell Regulation, Juntendo University Graduate School of Medicine, Tokyo, Japan
| | - Eriko Nishida
- Department of Pediatrics, Juntendo University Urayasu Hospital, Urayasu City, Japan
| | - Akiko Watanabe
- Department of Pediatrics, Juntendo University Urayasu Hospital, Urayasu City, Japan
| | - Naoto Nishizaki
- Department of Pediatrics, Juntendo University Urayasu Hospital, Urayasu City, Japan
| | - Kaoru Obinata
- Department of Pediatrics, Juntendo University Urayasu Hospital, Urayasu City, Japan
| | - Fumihiro Azuma
- Laboratory Department, Kanto-Koshinetsu Block Blood Center, Japanese Red Cross, Tokyo, Japan
| | - Mika Matsuhashi
- Laboratory Department, Kanto-Koshinetsu Block Blood Center, Japanese Red Cross, Tokyo, Japan
| | - Naoko Watanabe-Okochi
- Laboratory Department, Kanto-Koshinetsu Block Blood Center, Japanese Red Cross, Tokyo, Japan
| | - Nelson Hirokazu Tsuno
- Laboratory Department, Kanto-Koshinetsu Block Blood Center, Japanese Red Cross, Tokyo, Japan
| | - Kazunori Miyake
- Department of Laboratory Medicine, Juntendo University Urayasu Hospital, Urayasu City, Japan
| | | | - Koyo Yoshida
- Department of Obstetrics and Gynecology, Juntendo University Urayasu Hospital, Urayasu City, Japan
| | - Akimichi Ohsaka
- Department of Transfusion Medicine and Stem Cell Regulation, Juntendo University Graduate School of Medicine, Tokyo, Japan
| |
Collapse
|
4
|
Gimferrer I, Teramura G, Gallagher M, Warner P, Ji H, Chabra S. Implication of antibodies against human leukocyte antigen in simultaneous presentation of fetal and neonatal alloimmune thrombocytopenia and neutropenia. Transfus Apher Sci 2018; 57:773-776. [PMID: 30318177 DOI: 10.1016/j.transci.2018.09.018] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2018] [Revised: 09/21/2018] [Accepted: 09/25/2018] [Indexed: 12/27/2022]
Abstract
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) and neonatal alloimmune neutropenia (NAN) are two rare complications of newborns caused by antibodies against paternal inherited antigens. Human platelet (HPA) and neutrophil antigens (HNA) are the common targets. Human leukocyte antigen (HLA) class I proteins are also expressed on platelets and neutrophils and anti-HLA antibodies have occasionally been implicated in these complications. We report a premature twin infant who presented with severe thrombocytopenia and neutropenia clinically compatible with FNAIT and NAN, from a mother with no identifiable HPA or HNA antibodies, but with very high levels of complement-fixing antibodies against paternal inherited HLA. These antibodies were also detected in the infant. HLA antibodies are commonly present in multiparous women who deliver healthy infants. They can, however, be cytotoxic and cause clinical complications after blood products transfusion (TRALI and becoming refractory to platelets transfusion) and after organ transplantation (allogeneic organ rejection).
Collapse
Affiliation(s)
| | | | | | | | - Hongxiu Ji
- Department of Pathology, Overlake Hospital Medical Center, Bellevue, WA, United States
| | - Shilpi Chabra
- Division of Neonatology, Department of Pediatrics, University of Washington, Seattle, WA, United States
| |
Collapse
|
5
|
Meler E, Porta R, Canals C, Serra B, Lozano M. Fatal alloimmune thrombocytopenia due to anti-HLA alloimmunization in a twin pregnancy: A very infrequent complication of assisted reproduction. Transfus Apher Sci 2017; 56:165-167. [DOI: 10.1016/j.transci.2016.10.021] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2016] [Revised: 10/25/2016] [Accepted: 10/31/2016] [Indexed: 01/18/2023]
|
6
|
Crighton GL, Scarborough R, McQuilten ZK, Phillips LE, Savoia HF, Williams B, Holdsworth R, Henry A, Wood EM, Cole SA. Contemporary management of neonatal alloimmune thrombocytopenia: good outcomes in the intravenous immunoglobulin era: results from the Australian neonatal alloimmune thrombocytopenia registry. J Matern Fetal Neonatal Med 2016; 30:2488-2494. [DOI: 10.1080/14767058.2016.1253064] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- Gemma L. Crighton
- Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia,
- Australian Red Cross Blood Service, Melbourne, Australia,
- The Royal Children’s Hospital, Melbourne, Australia,
| | - Ri Scarborough
- Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia,
| | - Zoe K. McQuilten
- Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia,
- Australia and New Zealand Intensive Care Research Centre (ANZIC-RC), Melbourne, Australia,
| | - Louise E. Phillips
- Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia,
| | - Helen F. Savoia
- The Royal Children’s Hospital, Melbourne, Australia,
- The Royal Women’s Hospital, Melbourne, Australia,
| | - Bronwyn Williams
- Royal Brisbane and Women’s Hospital, Brisbane, Australia,
- Lady Cilento Children’s Hospital, Brisbane, Australia,
| | | | - Amanda Henry
- School of Women’s and Children’s Health, University of New South Wales, Australia,
- St George Hospital, Sydney, Australia, and
| | - Erica M. Wood
- Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia,
- Monash Medical Centre, Melbourne, Australia
| | | | | |
Collapse
|
7
|
Refsum E, Mörtberg A, Dahl J, Meinke S, Auvinen MK, Westgren M, Reilly M, Höglund P, Wikman A. Characterisation of maternal human leukocyte antigen class I antibodies in suspected foetal and neonatal alloimmune thrombocytopenia. Transfus Med 2016; 27:43-51. [DOI: 10.1111/tme.12375] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2015] [Revised: 10/04/2016] [Accepted: 10/09/2016] [Indexed: 12/29/2022]
Affiliation(s)
- E. Refsum
- Department of Laboratory Medicine; Karolinska Institutet, Stockholm, Sweden
| | - A. Mörtberg
- Department of Clinical Immunology and Transfusion Medicine; Karolinska University Hospital; Stockholm Sweden
| | - J. Dahl
- Department of Medical Biology, Immunology Research Group; Arctic University of Norway; Tromso Norway
| | - S. Meinke
- Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine (HERM); Karolinska Institutet; Stockholm Sweden
| | - M.-K. Auvinen
- Department of Clinical Immunology and Transfusion Medicine; Karolinska University Hospital; Stockholm Sweden
- Advanced Medical and Dental Institute; Universiti Sains Malaysia; George Town Malaysia
| | - M. Westgren
- Department of Obstetrics and Gynaecology; Karolinska University Hospital; Stockholm Sweden
| | - M. Reilly
- Department of Medical Epidemiology and Biostatistics; Karolinska Institutet; Stockholm Sweden
| | - P. Höglund
- Department of Clinical Immunology and Transfusion Medicine; Karolinska University Hospital; Stockholm Sweden
- Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine (HERM); Karolinska Institutet; Stockholm Sweden
| | - A. Wikman
- Department of Laboratory Medicine; Karolinska Institutet, Stockholm, Sweden
- Department of Clinical Immunology and Transfusion Medicine; Karolinska University Hospital; Stockholm Sweden
| |
Collapse
|
8
|
|